IMI is planning to launch Call 18 + 19 on 26 June 2019


The Innovative Medicines Initiative is planning to launch IMI2 – Call 18 and 19 on 26 June 2019 with the following topics:

IMI2 – Call 18:

  • Central repository of digital pathology slides to support the development of artificial intelligence tools;
  • Health Outcomes Observatories – empower patients with tools to measure their outcomes in a standardised manner creating transparency of health outcomes;
  • Improving patient access, understanding and adherence to healthcare information: an integrated digital health information project;
  • Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials;
  • Accelerating research & development for advanced therapy medicinal products;
  • Supporting the development of chimeric antigen receptor T cells.

IMI2 – Call 19: Restricted Call
This is a single stage restricted Call for proposals designed to support further research activities to allow existing successful IMI consortia to build on the achievements of their initial action, move onto the next step of the research challenge, and maximise the impacts of the initial action results. For more information, please visit the IMI Future Topics page

Draft topic texts are available on the IMI Future Topics page.